Citation | DeMong, D; Dai, X; Hwa, J; Miller, M; Lin, SI; Kang, L; Stamford, A; Greenlee, W; Yu, W; Wong, M; Lavey, B; Kozlowski, J; Zhou, G; Yang, DY; Patel, B; Soriano, A; Zhai, Y; Sondey, C; Zhang, H; Lachowicz, J; Grotz, D; Cox, K; Morrison, R; Andreani, T; Cao, Y; Liang, M; Meng, T; McNamara, P; Wong, J; Bradley, P; Feng, KI; Belani, J; Chen, P; Dai, P; Gauuan, J; Lin, P; Zhao, H The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist. J Med Chem57:2601-10 (2014) [PubMed] Article |
---|
SMILES | CCCCC[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:14.18,5.4,wD:11.12,c:9,(26.77,-29.67,;28.09,-28.88,;28.07,-27.34,;29.4,-26.56,;29.38,-25.02,;30.7,-24.23,;30.65,-22.69,;31.86,-21.74,;33.34,-22.16,;31.33,-20.3,;29.78,-20.36,;29.37,-21.83,;28.18,-20.85,;26.74,-21.38,;26.47,-22.9,;27.66,-23.88,;29.11,-23.35,;25.03,-23.43,;23.85,-22.45,;23.59,-23.96,;24.77,-24.95,;32.1,-18.97,;31.34,-17.63,;32.12,-16.3,;31.35,-14.97,;33.66,-16.31,;34.42,-17.65,;35.96,-17.66,;33.65,-18.98,;32.03,-25.02,;32.01,-26.56,;33.33,-27.35,;34.68,-26.59,;34.7,-25.06,;33.37,-24.27,;36,-27.39,;35.98,-28.92,;37.34,-26.63,;38.67,-27.42,;40.01,-26.66,;41.4,-27.3,;42.45,-26.17,;41.69,-24.82,;40.18,-25.13,)| |